Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Etanercept may not prevent alopecia areata from coming back.

A chest X-ray can effectively diagnose ectopic ACTH secretion from lung tumors.

rwSALT accurately measures hair regrowth in alopecia areata using scalp photos.

MSC exosome therapy improved hair quality in patients with acquired trichorrhexis nodosa.

Tacrolimus and corticosteroids can improve symptoms of Satoyoshi syndrome.

Estazolam reduces anxiety-like behavior in PTSD by increasing allopregnanolone levels.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The babassu fiber exfoliating product for hair loss should be stored in a cool place to stay effective.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Exclamation mark hairs and broken hairs best indicate active alopecia areata.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Children with atopic diseases have a higher risk of developing alopecia areata.

AMPLEX PLUS may reduce hair loss and promote new hair growth.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

Matrix effects in LC-MS can be managed but not completely avoided.

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.